Viewing nowCombinationHanol Neo 5/80 mg
Valsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Hanol Bio Pharma Co., Ltd.

MFDS item code 201308546 · Approved 2013.07.30 · Insurance code 655605570
Treatment of essential hypertension not controlled with amlodipine or valsartan monotherapy
This medication can be effectively used to manage essential hypertension when blood pressure is not adequately controlled with amlodipine or valsartan alone.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using either component, switching directly to this medicine may be considered, as follows. ㆍ 5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ 5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ 10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Pediatric patients under 18 years of age: Administration of this drug is not recommended because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters; therefore, if pregnancy is confirmed, it should be discontinued immediately. This medication should not be used by individuals with hypersensitivity to the active ingredient or similar compounds, by pregnant or breastfeeding women, or by patients with severe renal or liver dysfunction. For patients with sodium or fluid depletion, hypotension may occur, so it is important to thoroughly check the condition before taking this medication and to closely monitor blood pressure and condition during administration. Patients with hyperkalemia or those taking drugs that may increase potassium levels should have their potassium levels monitored regularly. Caution is advised when using this medication in patients with renal artery stenosis or who have received a kidney transplant, as it may affect renal function. If angioedema (swelling of the airway or face, lips, tongue) occurs, discontinue taking this medication immediately and do not take it again. Blood pressure and renal function should be closely monitored in patients with heart failure or after a myocardial infarction. This medication may rarely cause various side effects such as headache, dizziness, swelling, hypotension, cough, digestive disturbances, skin rashes, etc., so if any abnormal symptoms occur, consult a doctor or pharmacist. Caution is advised as dizziness or fatigue may occur during driving or operation of machinery. This medication may interact with other antihypertensive medications or certain drugs, so if currently taking other medications, it is essential to inform the healthcare provider and use it cautiously. Women who are planning to become pregnant or may be pregnant should not use this medication, and breastfeeding women should also avoid it. The safety and efficacy of this medication in children under 18 have not been adequately established, so its use is not recommended. In elderly patients, it can be administered in doses similar to those for adults, but careful observation of their condition is important. In case of overdose, hypotension and heart-related issues may arise; seek immediate medical attention for appropriate treatment.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, pod edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney injury, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, indigestion, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neurodermatitis, sensory impairment, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture. Additionally, drugs should be kept at room temperature between 1 and 30 degrees Celsius, avoiding extremely hot or cold places.
Dark yellow round film-coated tablet
PTP - 28 tablets/box [(14 tablets/PTP packaging × 2)], bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Hanol Bio Pharma Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.